Photo(chemo)therapy for cutaneous T-cell lymphoma

Dermatological Phototherapy and Photodiagnostic Methods

Volumn , Issue , 2009, Pages 135-149

  Hönigsmann, Herbert ^a   Tanew, Adrian ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b Universitatsklinik fur Dermatologie   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84857644171     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-36693-5_6     Document Type: Chapter

References (73)

1. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Duncan LM, Grange F, Harris NL, Kempf W, Kerl H, Kurrer M, Knobler R, Pimpinelli N, Sander C, Santucci M, Sterry W, Vermeer MH, Wechsler J, Whittaker S, Meijer CJ (2005) WHO-EORTC classifcation for cutaneous lymphomas. Blood 105:3768-3785
2. Querfeld C, Rosen ST, Guitart J, Kuzel TM (2005) The spectrum of cutaneous T-cell lymphomas: new insights into biology and therapy. Curr Opin Hematol 12:273-278
3. Foss F (2004) Mycosis fungoides and the Sézary syndrome. Curr Opin Oncol 16:421-428
4. Lamberg SI, Green SB, Byar DP et al (1984) Clinical staging for cutaneous T-cell lymphoma. Ann Intern Med 100:187-192
5. Kaye FJ, Bunn PA Jr, Steinberg S et al (1989) A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med 321:1784-1790
6. Jörg B, Kerl H, Thiers BH, Bröcker EB, Burg G (1994) Therapeutic approaches in cutaneous lymphoma. Dermatol Clin 12:433-441
7. Parrish JA, Fitzpatrick TB, Tanenbaum L, Pathak MA (1974) Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med 291:1207-1211
8. Milstein HI, Vonderheid EC, Van Scott EJ, Johnson WC (1982) Home ultraviolet phototherapy of early mycosis fungoides: preliminary observations. J Am Acad Dermatol 6:355-362
9. Resnik KS, Vonderheid EC (1993) Home UV phototherapy of early mycosis fungoides: longterm follow-up observations in thirty-one patients. J Am Acad Dermatol 29:73-77
10. Ramsay DL, Lish KM, Yalowitz CB, Soter NA (1992) Ultraviolet-B phototherapy for early-stage cutaneous T-cell lymphoma. Arch Dermatol 128:931-933
11. Hofer A, Cerroni L, Kerl H, Wolf P (1999) Narrowband (311-nm) UV-B therapy for small plaque parapsoriasis and early-stage mycosis fungoides. Arch Dermatol 135:1377-1380
12. Clark C, Dawe RS, Evans AT, Lowe G, Ferguson J (2000) Narrowband TL-01 phototherapy for patch-stage mycosis fungoides. Arch Dermatol 136:748-752
13. Ghodsi SZ, Hallaji Z, Balighi K, Safar F, Chams-Davatchi C (2005) Narrow-band UVB in the treatment of early stage mycosis fungoides: report of 16 patients. Clin Exp Dermatol 30:376-788
14. Boztepe G, Sahin S, Ayhan M et al (2005) Narrowband ultraviolet B phototherapy to clear and maintain clearance in patients with mycosis fungoides. J Am Acad Dermatol 53:242-246
15. Volc-Platzer B, Hönigsmann H (1995) Photoimmunology of PUVA and UVB therapy. In: Krutmann J, Elmets CA (eds) Photoimmunology. Blackwell Science, Oxford, pp 265-273
16. Ozawa M, Ferenczi K, Kikuchi T, et al (1999) 312-nanometer ultraviolet B light (narrowband UVB) induces apoptosis of T cells within psoriatic lesions. J Exp Med 189:711-718
17. Plettenberg H, Stege H, Megahed M, Ruzicka T, Hosokawa Y, Tsuji T, Morita A, Krutmann J (1999) Ultraviolet A1 (340-400 nm) phototherapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 41:47-50
18. Zane C, Leali C, Airo P, De Panflis G, Pinton PC (2001) "High-dose" UVA1 therapy of widespread plaque-type, nodular, and erythrodermic mycosis fungoides. J Am Acad Derma-tol 44:629-633
19. Gilchrest BA, Parrish JA, Tanenbaum L, Haynes HA, Fitzpatrick TB (1976) Oral methox-salen photochemotherapy of mycosis fungoides. Cancer 38:683-689
20. Tanew A, Hönigsmann H (1997) Ultraviolet B and psoralen plus U VA phototherapy for cutaneous T-cell lymphoma. Dermatol Ther 4:38-46
21. Herrmann Jr, Roenigk HH Jr, Hönigsmann H (1995) Ultraviolet radiation for treatment of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 9:1077-1088
22. Abel EA, Sendagorta E, Hoppe RT, Hu CH (1987) PUVA treatment of erythrodermic and plaque-type mycosis fungoides. Arch Dermatol 123:897-901
23. Querfeld C, Rosen ST, Kuzel TM, Kirby KA, Roenigk HH Jr, Prinz BM, Guitart J (2005) Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy. Arch Dermatol 141:305-311
24. Hönigsmann H, Brenner W, Rauschmeier W, Konrad K, Wolff K (1984) Photochemotherapy for cutaneous T cell lymphoma. J Am Acad Dermatol 10:238-245
25. Powell FC, Spiegel GT, Muller SA (1984) Treatment of parapsoriasis and mycosis fungoides: the role of psoralen and long-wave ultraviolet light A (PUVA). Mayo Clin Proc 59:538-546
26. Rosenbaum MM, Roenigk HH Jr, Caro WA, Esker A (1985) Photochemotherapy in cutaneous T cell lymphoma and parapsoriasis en plaques. J Am Acad Dermatol 13:613-622
27. Vella Briffa D, Warin AP, Harrington CI, Bleehen SS (1980) Photochemotherapy in mycosis fungoides. Lancet 2:49-53
28. Weber F, Schmuth M, Sepp N, Fritsch P (2005) Bath-water PUVA therapy with 8-methoxyp-soralen in mycosis fungoides. Acta Derm Venereol 85:329-332
29. Holloway KB, Flowers FP, Ramos-Caro FA (1992) Therapeutic alternatives in cutaneous T-cell lymphoma. J Am Acad Dermatol 27:367-378
30. Hoppe R (1991) The management of mycosis fungoides at Stanford-standard and innovative treatment programs. Leukemia 5[Suppl 1]:46-48
31. Vonderheid EC, Tan ET, Kantor AF, Shrager L, Micaily B, van Scott EJ (1989) Long-term effcacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma. J Am Acad Dermatol 20:416-428
32. Zackheim HS, Epstein EH Jr, Crain WR (1990) Topical carmustine (BCNU) for cutaneous T cell lymphoma: a 15-year experience in 143 patients. J Am Acad Dermatol 22:802-810
33. Hamminga B, Noordijk EM, van Vloten WA (1982) Treatment of mycosis fungoides. Total-skin electron-beam irradiation vs topical mechlorethamine therapy. Arch Dermatol 118:150-153
34. Kim YH, Jensen RA, Watanabe GL, Varghese A, Hoppe RT (1996) Clinical stage la (limited patch and plaque) mycosis fungoides. A long-term outcome analysis. Arch Dermatol 132:1309-1313
35. Claudy AL, Rouchouse B (1985) Treatment of cutaneous T cell lymphoma with retinoids. In: Saurat JH (ed) Retinoids: new trends in research and therapy. Retinoid symposium, Geneva, 1984. Karger, Basel, pp 335-340
36. Kessler JF, Jones SE, Levine N, Lynch PJ, Rohman Both A, Meyskens L Jr (1987) Isotretinoin and cutaneous helper T cell lymphoma (mycosis fungoides). Arch Dermatol 123:201-204
37. Mahrle G, Thiele B (1987) Retinoids in cutaneous T cell lymphomas. Dermatologica 175[Suppl 1]:145-150
38. Molin L, Thomsen K, Volden G et al (1987) Oral retinoids in mycosis fungoides and Sézary syndrome: a comparison of isotretinoin and etretinate. Acta Derm Venereol (Stockh) 67:232-236
39. Thomsen K, Molin L, Volden G, Lange Wantzin G, Hellbe L (1984) 13-cis-retinoic acid effective in mycosis fungoides. Acta Derm Venereol (Stockh) 64:563-566
40. Thomsen K, Hammar H, Molin L, Volden G (1989) Retinoids plus PUVA (RePUVA) and PUVA in mycosis fungoides, plaque stage. Acta Derm Venereol (Stockh) 69:536-538
41. Serri F, De Simone C, Venier A, Rusciani L, Marchetti E (1990) Combination of retinoids and PUVA (Re-PUVA) in the treatment of cutaneous T-cell lymphomas. Curr Probl Dermatol 19:252-257
42. Singh F, Lebwohl MG (2004) Cutaneous T-cell lymphoma treatment using bexarotene and PUVA: a case series. J Am Acad Dermatol 51:570-573
43. Coors EA, Vo n den Driesch P (2005) Treatment of mycosis fungoides with bexarotene and psoralen plus ultraviolet A. Br J Dermatol 152:1379-1381
44. Zhang C, Duvic M (2003) Retinoids: therapeutic applications and mechanisms of action in cutaneous T-cell lymphoma. Dermatol Ther 16:322-330
45. Bunn PA Jr, Foon KA, Ihde DC et al (1984) Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas. Ann Intern Med 101:484-487
46. Olsen EA, Bunn PA (1995) Interferon in the treatment of cutaneous T-cell lymphoma. Hema-tol Oncol Clin North Am 9:1089-1107
47. Thestrup-Pedersen K (1990) Interferon therapy in cutaneous T-cell lymphoma. Curr Probl Dermatol 19:258-263
48. Kuzel TM, Gilyon K, Springer E et al (1990) Interferon alfa-2a combined with phototherapy in the treatment of cutaneous T-cell lymphoma. J Natl Cancer Inst 82:203-207
49. Kuzel TM, Roenigk HH Jr, Samuelson E et al (1995) Effectiveness of interferon alfa-2a combined with phototherapy for mycosis fungoides and the Seizure syndrome. J Clin Oncol 13:257-263
50. Otte HG, Herges A, Stadler R (1992) Kombinationstherapie mit Interferon α2a und PUVA bei kutanen T-Zell-Lymphomen. Hautarzt 43:695-699
51. Mostow EN, Neckel SL, Oberhelman L, Anderson TF, Cooper KD (1993) Complete remissions in psoralen and U VA (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA. Arch Dermatol 129:747-752
52. Stadler R, Otte HG, Luger T, Henz BM, Kuhl P, Zwingers T, Sterry W (1998) Prospective randomized multicenter clinical trial on the use of interferon-2α plus acitretin versus interferon-2α plus PUVA in patients with cutaneous T-cell lymphoma stages I and II. Blood 92:3578-3581
53. Rupoli S, Goteri G, Pulini S, Filosa A, Tassetti A, Offdani M, Filosa G, Mozzicafreddo G, Giacchetti A, Brandozzi G, Cataldi I, Barulli S, Ranaldi R, Scortechini AR, Capretti R, Fabris G, Leoni P (2005) Marche Regional Multicentric Study Group of Cutaneous Lymphomas. Long-term experience with low-dose interferon-alpha and PUVA in the management of early mycosis fungoides. Eur J Haematol 75:136-145
54. Kuzel TM, Roenigk HH Jr, Samuelson E, Rosen ST (1992) Suppression of anti-interferon α-2a antibody formation in patients with mycosis fungoides by exposure to longwave UV radiation in the A range and methoxsalen ingestion. J Natl Cancer Inst 84:119-121
55. Rajan GP, Seifert B, Prümmer O, Joller-Jemelka HI, Burg G, Dummer R (1996) Incidence and in-vivo relevance of antiinterferon antibodies during treatment of low-grade cutaneous T-cell lymphomas with interferon alpha-2a combined with acitretin or PUVA. Arch Dermatol Res 288:543-548
56. Tanew A, Ortel B, Rappersberger K, Hönigsmann H (1988) 5-Methoxypsoralen (Bergapten) for photochemotherapy. J Am Acad Dermatol 18:333-339
57. Henseler T, Wolff K, Hönigsmann H, Christophers E (1981) Oral 8-methoxypsoralen photo-chemotherapy of psoriasis. Lancet i:853-857
58. Roenigk HH Jr (1977) Photochemotherapy for mycosis fungoides. Arch Dermatol 113:1047-1051
59. Wolff K, Gschnait F, Hönigsmann H, Konrad K, Parrish JA, Fitzpatrick TB (1977) Phototest-ing and dosimetry for photochemotherapy. Br J Dermatol 96:1-10
60. Lowe NJ, Cripps DJ, Dufton PA, Vickers CFH (1979) Photochemotherapy for mycosis fun-goides. A clinical and histological study. Arch Dermatol 115:50-53
61. Volden G, Thune PO (1977) Light sensitivity in mycosis fungoides. Br J Dermatol 97:279-284
62. Molin L, Volden G (1987) Treatment of light-sensitive mycosis fungoides with PUVA and prednisolone. Photodermatol Photoimmunol Photomed 4:106-107
63. Du Vivier A, Vollum DI (1980) Photochemotherapy and topical nitrogen mustard in the treatment of mycosis fungoides. Br J Dermatol 102:319-322
64. Whittaker SJ, Marsden JR, Spittle M, Russell Jones R (2003) British Association of Dermatologists; U.K. Cutaneous Lymphoma Group Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas. Br J Dermatol 149:1095-1107
65. Johnson R, Staiano-Coico L, Austin L, Cardinale I, Nabeya-Tsukifuji R, Krueger JG (1996) PUVA treatment selectively induces a cell cycle block and subsequent apoptosis in human T-lymphocytes. Photochem Photobiol 63:566-571
66. Hönigsmann H, Tanew A, Wolff K (1987) Treatment of mycosis fungoides with PUVA. Pho-todermatol Photoimmunol Photomed 4:55-58
67. Maier H, Schemper M, Ortel B, Binder M, Tanew A, Hönigsmann H (1996) Skin tumors in photochemotherapy for psoriasis. A single center follow-up of 496 patients. Dermatology 193:185-191
68. Stern RS, Lunder EJ (1998) Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis. Arch Dermatol 134:1582-1585
69. Studniberg HM, Weller P (1993) PUVA, UVB, psoriasis, and nonmelanoma skin cancer. J Am Acad Dermatol 29:1013-102
70. Abel EA, Sendagorta E, Hoppe RT (1986) Cutaneous malignancies and metastatic squamous cell carcinoma following topical therapies for mycosis fungoides. J Am Acad Dermatol 14:1029-1038
71. Smoller BR, Marcus R (1994) Risk of secondary cutaneous malignancies in patients with long-standing mycosis fungoides. J Am Acad Dermatol 30:201-204
72. Herrmann JJ, Roenigk HH Jr, Hurria A et al (1995) Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up. J Am Acad Dermatol 33:234-242
73. Swanbeck G, Roupe G, Sandström MH (1994) Indications of a considerable decrease in the death rate in mycosis fungoides by PUVA treatment. Acta Derm Venereol (Stockh) 74:465-466